Hikma Pharmaceuticals Plc (HKMPF) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	845.50M	845.50M	864.00M	864.00M
Cost of goods sold	479.50M	479.50M	477.00M	477.00M
Cost of revenue	479.50M	479.50M	477.00M	477.00M
Research and development expenses	39.00M	39.00M	43.00M	43.00M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	194.00M	194.00M	141.00M	141.00M
Operating expense	229.00M	229.00M	184.00M	184.00M
Total operating expenses	708.50M	708.50M	661.00M	661.00M
Operating income	137.00M	137.00M	203.00M	203.00M
Other non operating income	-6.00M	-6.00M	-	-
EBT including unusual items	112.00M	112.00M	143.50M	143.50M
EBT excluding unusual items	104.00M	104.00M	178.50M	178.50M
Income tax expense	28.50M	28.50M	31.00M	31.00M
Effective tax rate	25.45%	25.45%	21.60%	21.60%
Other operating expenses	-4.00M	-4.00M	-	-
Net income	82.00M	82.00M	111.50M	111.50M
Net profit margin	9.70%	9.70%	12.90%	12.90%
Earnings per share	-	-	-	-
Interest and investment income	1.00M	1.00M	1.50M	1.50M
Interest expense	-22.50M	-22.50M	-26.00M	-26.00M
Net interest expenses	-21.50M	-21.50M	-24.50M	-24.50M
Depreciation and amortization charges	-	-	-	-
EBITDA	183.00M	183.00M	250.50M	250.50M
Gain or loss from assets sale	500.00K	500.00K	-	-

Finance